Search results
Results from the WOW.Com Content Network
William Bradley Coley (January 12, 1862 – April 16, 1936) was an American bone surgeon and cancer researcher best known for his early contributions to the study of cancer immunotherapy, specifically causing infection as a way to fight cancer, a practice used as far back as 1550 BC. [1]
Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies .
Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology ( immuno-oncology ) and a growing subspecialty of oncology .
For premium support please call: 800-290-4726 more ways to reach us
Image credits: Old-time Photos To learn more about the fascinating world of photography from the past, we got in touch with Ed Padmore, founder of Vintage Photo Lab.Ed was kind enough to have a ...
J. Fred Muggs (born March 14, 1952) is a chimpanzee born in the African colony of French Cameroon that forms part of modern-day Cameroon.Brought to New York City before his first birthday, he was bought by two former NBC pages and eventually appeared on a host of television shows on that network including NBC's Today Show where he served as mascot from 1953 to 1957.
“Immunotherapy is now considered a standard pillar of cancer therapy alongside surgery, radiation, chemotherapy, and targeted therapy,” Dr. Jedd Wolchok, chief of the immuno-oncology service ...
The Immune Response Corporation (IRC) was a pharmaceutical company that worked in the development of immunotherapeutic products. The firm was founded by Jonas Salk and Kevin Kimberlin when Kimberlin, "asked Salk to become lead scientific advisor for a new biotech company specializing in 'anti-idiotypes,' a novel vaccine technology."